PPT-ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy

From ESH 2016 LB 1 JeanPierre Fauvel MD CHU Lyon Hôpital E Herriot Lyon France Overview Online risk prediction tool created to aid optimizing treatment of diabetic nephropathy. by . Zubair. Shah, PGY-III. Research Mentor:. Dr. Yuji Saito, M.D., Ph.D., FACP, FACC. INTRODUCTION. Diabetes mellitus is known to increase the risk of heart failure even in the absence of frequently coexisting predisposing/risk factors including coronary artery disease and hypertension.. Patel University. Efficacy of Urinary N-Acetyl β- D- Glucosaminidase in Detecting Renal Tubular Damage: A Early Consequence in Type 2 Diabetes Mellitus leading to Diabetic Nephropathy. Kiran. . Sierra Nevada Nephrology Consultants. Outline. Define the illness. Recent state of Affairs. Pathology. Risk factors. Medication. Treatments. Diabetic nephropathy is a clinical . syndrome. Persistent . Parviz. . Shabane. Ramu Anandakrishnan. Arichanah. . Pulenthiran. Harold Garner. CNDP1 is an excreted . dipeptidase. that exists as a monomer or . homodimer. Its two . substrates are H-carnosine (preferred) and . IN. TYPE I DIABETIC NEPHROPATHY. DR.NASIM MUSA. Type I –IDDM is characterized by. The abrupt onset of symptoms. Insulinopenia. Dependence on injected insulin for life. Proneness to . ketoacidosis. .. kidney disease . in . diabetes :. In . either . type 1 or . type 2 diabetes : . 25 – 40. % . → diabetic . nephropathy in a 25 . y. Diabetes . → leading cause for ESRD. diabetic . nephropathy :. Objectives and background for this learning resource. Introduction:. This learning resource has been developed as part of a medical education initiative supported by Janssen. . The content of this slide kit has been developed by an advisory board of renal physicians, GPs and specialist nurses. The panel of experts . Egypt Rheumatol Rehab Vol. 30. No. 3, May, 2003 367Hemoglobin A is specifically eluted after washing away the HbA1fraction, and is quantified by direct photometric reading at 4/5 nm. The columns we 5 5 DOI: 10.7860/JCDR/2018/36574.12203 Original Article Miscellaneous Postgraduate Education Letter to Editor Short Communication Images in Medicine Experimental Research Clinician’s corner Revie P. Risk factors in the progression of dia-betic nephropathies. Ugeskr Laeger 2000; 162:P, NARVINGNatural course of kidney function in type 2 diabet-ic patients with diabetic nephropathy. Diabet Med199 1 (IgAN) Prediction Tool Information for nephrologists & other healthcare professionals What does th e IgAN Prediction T ool do ?  The Prediction Tool accurately predicts at the time of kidney b P. Belton, M. Carmody, J. Doino:hue and W. F. O'Dwyer of Nephrology, Jervis Street Hospital, Dublin 1. I gA nephropathy is a newly described glomerulonephritis. It is a relatively common nephritis o Rodica. Pop-. Busui. , M.D., . Ph.D. Division of Metabolism, Endocrinology and Diabetes. Michigan Comprehensive Diabetes Center. University of . Michigan. Diabetes is the dominant cause of ESRD in USA. . Shahin. . Nosratzehi. . volume . 14 | JUNE 2018 | . 361. Agenda. Introduction. Classical phenotype. Mechanisms of . DKD. Immediate effects of . hyperglycemia. Late effects of . hyperglycemia. Non-protein uric phenotype.